Let technology forever honour life
Advancing the convergence of carbon-based and silicon-based life
自研仪器 + 组学科技服务，支撑生命科学研究全流程。
临床生化、免疫、微生物与病理检验，服务临床精准诊断。
28,000 m² 智造基地，C2M 工厂直供，耗材试剂品质如一。
Milestones
The path of Yuanzan’s growth
- 2019集团公司成立
- 2020Pre-A轮融资
初 · 投资方：禧堂孵化器、重庆信展
- 2020公司重组
中 · 泰煜投资、西科天使基金等多家机构参与
- 2020A轮融资
11月 · 投资方：著名投资人段力平
- 2024B轮融资
9月
Our culture
No Limits, Do No Evil — innovate without boundaries, and hold the line on what we will not do.
Make every test more accurate and dependable, and put good life science tools within reach.
Build core technology in house, and deliver integrated sample-to-result solutions for research and clinical work.
Innovation platform
Built on macrofluidic droplet technology, the company operates four instrument platforms (cell sorting, PCR, nucleic acid extraction and single-molecule immunoassay) to bring nucleic acid diagnostic instrumentation in house, with deep coverage of four molecular diagnostic areas: pathogens, oncology, genetics and reproductive health.
An innovative microfluidic platform providing the core technology for precision diagnostics.
High-precision cell sorting and analysis systems
High-throughput PCR testing platform
Automated nucleic acid extraction solutions
Ultra-sensitive immunoassay technology
Pathogen detection and diagnosis
Early cancer screening and precision therapy
Genetic disease screening and diagnosis
Reproductive health testing
A concentration of talent
Our scientists and engineers come from leading universities and established companies worldwide. Specialists from many disciplines exchange ideas here and work together on frontier problems in the life sciences.
We encourage every breakthrough idea and support every bold attempt, carrying Chinese engineering to the world through continuous innovation and redefining what is possible in the life sciences.
Global presence
News
Ruijin · CEIBS – Ganzhou hospital directors' programme opens: a new standard for public hospital training
Four institutions — Ruijin Hospital (Shanghai Jiao Tong University), CEIBS, the Ganzhou Health Commission and Xinhua's National Brand Project Office — jointly launched this programme for hospital directors, in support of "Healthy China 2030" and county-level care.
Read more →
Malaysia–China Life Science R&D Forum 2024 held in Kuala Lumpur
On 14 October 2024, marking fifty years of China–Malaysia relations, the Malaysia–China Life Science R&D Forum opened at Taylor's University, Kuala Lumpur, on the theme "Innovation-driven, healthier future".
Read more →Contact us
Leave your request and our team will contact you shortly, or email us directly.